These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30833420)

  • 1. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
    Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
    Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
    Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
    Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
    Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
    Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
    Colyn L; Bárcena-Varela M; Álvarez-Sola G; Latasa MU; Uriarte I; Santamaría E; Herranz JM; Santos-Laso A; Arechederra M; Ruiz de Gauna M; Aspichueta P; Canale M; Casadei-Gardini A; Francesconi M; Carotti S; Morini S; Nelson LJ; Iraburu MJ; Chen C; Sangro B; Marin JJG; Martinez-Chantar ML; Banales JM; Arnes-Benito R; Huch M; Patino JM; Dar AA; Nosrati M; Oyarzábal J; Prósper F; Urman J; Cubero FJ; Trautwein C; Berasain C; Fernandez-Barrena MG; Avila MA
    Hepatology; 2021 Jun; 73(6):2380-2396. PubMed ID: 33222246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
    Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
    Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
    [No Abstract]   [Full Text] [Related]  

  • 10. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
    Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
    Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.
    Wang L; Dong X; Ren Y; Luo J; Liu P; Su D; Yang X
    Cell Death Dis; 2018 Jan; 9(2):129. PubMed ID: 29374157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
    Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A
    Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis.
    Barcena-Varela M; Paish H; Alvarez L; Uriarte I; Latasa MU; Santamaria E; Recalde M; Garate M; Claveria A; Colyn L; Arechederra M; Iraburu MJ; Milkiewicz M; Milkiewicz P; Sangro B; Robinson SM; French J; Pardo-Saganta A; Oyarzabal J; Prosper F; Rombouts K; Oakley F; Mann J; Berasain C; Avila MA; G Fernandez-Barrena M
    Gut; 2021 Feb; 70(2):388-400. PubMed ID: 32327527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability.
    Lee JY; Lee SH; Heo SH; Kim KS; Kim C; Kim DK; Ko JJ; Park KS
    PLoS One; 2015; 10(10):e0141118. PubMed ID: 26492085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
    Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
    Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
    Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
    Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
    Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Lin X; Huang Y; Zou Y; Chen X; Ma X
    Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells.
    Shrestha R; Mohankumar K; Jin UH; Martin G; Safe S
    Mol Cancer Ther; 2021 Mar; 20(3):612-622. PubMed ID: 33277444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Methyltransferase G9a Regulates Expression of Nuclear Receptors and Cytochrome P450 Enzymes in HepaRG Cells at Basal Level and in Fatty Acid Induced Steatosis.
    Pande P; Zhong XB; Ku WW
    Drug Metab Dispos; 2020 Dec; 48(12):1321-1329. PubMed ID: 33077425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.